Oclacitinib maleate is a synthetic cyclohexylamino pyrrolopyrimidine compound that functions as a janus kinase inhibitor, primarily used in veterinary medicine. It is supplied as an active pharmaceutical ingredient for the manufacture of formulations intended to control pruritus associated with allergic dermatitis in dogs.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1208319-27-0
OCLACITINIB MALEATE
pharmaceutical raw material
Oclacitinib
active pharmaceutical ingredient for veterinary use
Amprolium chloride
pharmaceutical raw material
Benzethonium chloride
pharmaceutical raw material
Nelarabine
pharmaceutical raw material
Ertugliflozin
pharmaceutical raw material
(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
VQIGDTLRBSNOBV-BTJKTKAUSA-N
CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3.C(=C\C(=O)O)\C(=O)O